Cargando…

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

PURPOSE: To explore the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with breast cancer based on type of anticancer treatment. METHODS: Patients with breast cancer had anti-spike antibody concentrations measured ⩾14 days after receiving a full S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denault, Elyssa, Nakajima, Erika, Naranbhai, Vivek, Hutchinson, Jennifer A., Mortensen, Lindsey, Neihoff, Elizabeth, Barabell, Caroline, Comander, Amy, Juric, Dejan, Kuter, Irene, Mulvey, Theresa, Peppercorn, Jeffrey, Rosenstock, Aron S., Shin, Jennifer, Vidula, Neelima, Wander, Seth A., Moy, Beverly, Ellisen, Leif W., Isakoff, Steven J., Iafrate, A. John, Gainor, Justin F., Bardia, Aditya, Spring, Laura M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425892/ https://www.ncbi.nlm.nih.gov/pubmed/36051470 http://dx.doi.org/10.1177/17588359221119370

Ejemplares similares

Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2023)

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
por: Medford, Arielle J., et al.
Publicado: (2019)

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
por: McLaughlin, Shannon, et al.
Publicado: (2023)

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2021)

Novel antibody–drug conjugates for triple negative breast cancer
por: Nagayama, Aiko, et al.
Publicado: (2020)

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)
por: Isakoff, Steven J., et al.
Publicado: (2023)

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer
por: Spring, Laura M., et al.
Publicado: (2021)

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic
por: Spring, Laura M., et al.
Publicado: (2020)

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
por: Coates, James T., et al.
Publicado: (2021)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
por: Spring, Laura M., et al.
Publicado: (2017)

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
por: Naranbhai, Vivek, et al.
Publicado: (2022)

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2022)

Mechanisms of Resistance to Antibody–Drug Conjugates
por: Abelman, Rachel Occhiogrosso, et al.
Publicado: (2023)

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis
por: Medford, Arielle J., et al.
Publicado: (2023)

Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
por: Scarpetti, Lauren, et al.
Publicado: (2023)

Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Meador, Catherine B., et al.
Publicado: (2023)

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry
por: Smith, Barbara L., et al.
Publicado: (2020)

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer
por: McCarthy, Anne Marie, et al.
Publicado: (2020)

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
por: Brett, Jamie O., et al.
Publicado: (2021)

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
por: Koh, Siang-Boon, et al.
Publicado: (2021)

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
por: Naranbhai, Vivek, et al.
Publicado: (2022)

Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series
por: Brett, Jamie O, et al.
Publicado: (2022)

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
por: Bowes, Cynthia L., et al.
Publicado: (2022)

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
por: Spring, Laura M., et al.
Publicado: (2022)

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
por: Spring, Laura M., et al.
Publicado: (2022)

Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital
por: Bardia, Aditya, et al.
Publicado: (2016)

Androgen receptor gene expression in primary breast cancer
por: Vidula, Neelima, et al.
Publicado: (2019)

Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors
por: Finkelstein-Fox, Lucy, et al.
Publicado: (2022)

Remember Your Why: An Oncologist's Reflections on Running During the COVID‐19 Pandemic
por: Comander, Amy
Publicado: (2021)

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
por: Dias-Santagata, Dora, et al.
Publicado: (2010)

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
por: Tanaka, Shota, et al.
Publicado: (2019)

Announcing a New Journal Section: Community Outreach
por: Evans, Michele, et al.
Publicado: (2016)

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role
por: Lloyd, Maxwell R., et al.
Publicado: (2022)

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2
por: Voutouri, Chrysovalantis, et al.
Publicado: (2023)

Cognitive Computing to Guide Molecular‐Based Therapy Selection: Steps Forward amid Abundant Need
por: Ellisen, Leif W.
Publicado: (2018)

A wound-healing program is hijacked to promote cancer metastasis
por: Ellisen, Leif W.
Publicado: (2017)

A Comparison of the Clinical Presentation of Ovarian Hyperstimulation Syndrome in a Partial Molar Pregnancy Case Versus a Fertility Treatment Case
por: Cohen, Elyssa, et al.
Publicado: (2019)

Characterizing variants of unknown significance in rhodopsin: A functional genomics approach
por: Wan, Aliete, et al.
Publicado: (2019)

Improving the statistical detection of regulated genes from microarray data using intensity-based variance estimation
por: Comander, Jason, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ma4l2ukvmmarbdvtrmumg02agc